These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37487707)

  • 1. Carbon 14 and stable isotope synthesis of two potent and selective phosphodiesterase type 4 inhibitors.
    Latli B; Hrapchak MJ; Tampone TG; Frutos RP; Lee H
    J Labelled Comp Radiopharm; 2023 Sep; 66(11):353-361. PubMed ID: 37487707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of empagliflozin, a novel and selective sodium-glucose co-transporter-2 inhibitor, labeled with carbon-14 and carbon-13.
    Hrapchak M; Latli B; Wang XJ; Lee H; Campbell S; Song JJ; Senanayake CH
    J Labelled Comp Radiopharm; 2014 Oct; 57(12):687-94. PubMed ID: 25332189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 labeled with carbon-13 and carbon-14.
    Latli B; Hrapchak M; Savoie J; Zhang Y; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2017 Jul; 60(9):420-430. PubMed ID: 28494515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of BI 894416 and BI 1342561, two potent and selective spleen tyrosine kinase inhibitors, labeled with carbon 14 and with deuterium.
    Latli B; Hrapchak MJ; Samankumara LP; Fandrick DR; Pennino S; Lee H; Song JJ
    J Labelled Comp Radiopharm; 2023; 66(4-6):155-168. PubMed ID: 37057686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses of [14C]-labeled 2-(3-chlorophenyloxy)-3-[3-(3-hydroxy) pyridin-4-yl propoxy]pyridine, a phosphodiesterase 4 inhibitor and its metabolites.
    Ochi T; Sawayama Y; Kawasaki M; Nigo T; Nakao M; Omodani T; Sumiyoshi T
    J Labelled Comp Radiopharm; 2014 Jun; 57(7):477-9. PubMed ID: 24966159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of highly potent lymphocyte function-associated antigen-1 antagonists labeled with carbon-14 and with stable isotopes, part 3.
    Latli B; Hrapchak M; Li G; Lorenz J; Horan J; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2019 Feb; 62(2):77-85. PubMed ID: 30466143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent IκB kinase-β inhibitor labeled with carbon-14 and deuterium.
    Latli B; Eriksson M; Hrapchak M; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2016 Jun; 59(8):300-4. PubMed ID: 27073120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of two potent glucocorticoid receptor agonists labeled with carbon-14 and stable isotopes.
    Latli B; Reeves JT; Tan Z; Hrapchak M; Song JJ; Busacca CB; Senanayake CH
    J Labelled Comp Radiopharm; 2015; 58(11-12):445-52. PubMed ID: 26391408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium.
    Latli B; Hrapchak M; Gao JJ; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2015 Jul; 58(9):390-4. PubMed ID: 26190342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of deleobuvir, a potent hepatitis C virus polymerase inhibitor, and its major metabolites labeled with carbon-13 and carbon-14.
    Latli B; Hrapchak M; Chevliakov M; Li G; Campbell S; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2015 May; 58(6):250-60. PubMed ID: 25964148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus serine protease: synthesis of radioactive and stable isotope-labeled potent inhibitors.
    Latli B; Hrapchak M; Gorys V; Llinàs-Brunet M; Campbell SS; Song J; Senanayake CH
    J Labelled Comp Radiopharm; 2014 May; 57(5):350-7. PubMed ID: 24700697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of
    Fontana E; Cenacchi V; Pivetti F; Pignatti A; Pazzi T; Bondanza L; Pazzi M
    J Labelled Comp Radiopharm; 2017 Oct; 60(12):577-585. PubMed ID: 28763109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation.
    Jia L; Miao C; Dong F; Li W; Wang M; Zheng QH; Xu Z
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1654-1659. PubMed ID: 31047754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon 14 synthesis of glycine transporter 1 inhibitor Iclepertin (BI 425809) and its major metabolites.
    Latli B; Hrapchak MJ; Frutos RP; Lee H; Song JJ
    J Labelled Comp Radiopharm; 2023 Sep; 66(11):336-344. PubMed ID: 37382087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.
    Cashman JR; Voelker T; Zhang HT; O'Donnell JM
    J Med Chem; 2009 Mar; 52(6):1530-9. PubMed ID: 19256502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicity.
    Davis TG; Peterson JJ; Kou JP; Capper-Spudich EA; Ball D; Nials AT; Wiseman J; Solanke YE; Lucas FS; Williamson RA; Ferrari L; Wren P; Knowles RG; Barnette MS; Podolin PL
    J Pharmacol Exp Ther; 2009 Sep; 330(3):922-31. PubMed ID: 19498103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, Synthesis, and Characterization of Potential Oxidative Impurities of Venetoclax: Application of Meisenheimer Rearrangement.
    Vaddamanu G; Goswami A; Nandipati RSR; Malireddy YT; Katam Reddy VKR; Mulakayala N
    ACS Omega; 2023 Oct; 8(41):38494-38505. PubMed ID: 37867659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of carbon-11-labeled CK1 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease.
    Gao M; Wang M; Zheng QH
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2234-2238. PubMed ID: 29859907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues.
    Kenk M; Greene M; Lortie M; Dekemp RA; Beanlands RS; Dasilva JN
    Nucl Med Biol; 2008 May; 35(4):515-21. PubMed ID: 18482689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-proton exchanger isoform-1: synthesis of a potent inhibitor labeled with deuterium and carbon-14.
    Latli B; Haddad N; Hrapchak M; Wei X; Tang W; Song JJ; Senanayake CH
    Curr Radiopharm; 2013 Mar; 6(1):7-11. PubMed ID: 23256768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.